MilliporeSigma, the U.S. and Canadian Life Science unit of Merck KGaA (Darmstadt, Germany) announced today that it opened a new $317 million (€290) biosafety testing facility in Rockville, Maryland. The 23,000-square-meter facility houses biosafety testing, analytical development and cell banking manufacturing services. It consolidates labs currently spread across four buildings into one single facility. MilliporeSigma…
Merck KGaA completes €180M Schnelldorf distribution center expansion
Merck KGaA, Darmstadt, Germany announced that it opened its newly expanded Life Science distribution center in Schnelldorf. The company invested €180 million and added 25,000 square meters in space to the site, nearly doubling its size. It now features a manual down filling operation and additional space for the distribution of products to laboratories and…
MilliporeSigma to invest €300M in new bioprocessing plant in South Korea
MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA (Darmstadt, Germany), announced a €300 million in South Korea. The investment goes toward a new bioprocessing production center in Daejon, South Korea. It marks the largest investment by the company’s life science business sector in Asia-Pacific to date. The company expects the investment to…
Roche to donate essential medicines to Ukraine
Roche (SIX:RO, ROG; OTCQX:RHHBY) announced that it would ship 150,000 packages of the antibiotic Rocephin to Ukraine, among other medical supplies, including diagnostics. Rocephin is a broad-spectrum cephalosporin antibiotic. The World Health Organization cites it as an essential medicine. Basel, Switzerland–headquartered Roche noted in a statement that it is working with various international and local…
Merck KGaA, Darmstadt, Germany acquires Exelead to bolster mRNA offerings
Merck KGaA, Darmstadt, Germany has announced that it has signed a definitive agreement to purchase Exelead (Indianapolis), a biopharma contract development and manufacturing organization (CDMO). Not to be confused with the similarly named Merck & Co., the German company will pay roughly $780 million in the acquisition. Exelead specializes in creating lipid nanoparticle and pegylated…